Triheptanoin
- Part D specialty tier in 58% of formularies (2026Q3)
- DOJOLVI
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Triheptanoin: storage and handling
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- at or below 30°C (86°F)
Label statement
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).
- Room temperature
- at or below 25°C (77°F)
Label statement
Store DOJOLVI at room temperature between 68°F to 77°F (20°C to 25°C).
- Room temperature
- at or below 77°F
Label statement
Store DOJOLVI at room temperature between 68°F to 77°F.
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (10)
- Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).
- Do not freeze.
- DOJOLVI can be used for up to 9 months after opening but not beyond the expiration date on the bottle.
- Do not dose or store using materials made of polystyrene or polyvinyl chloride (PVC) containers [see Dosage and Administration (2.4) ] .
- Store DOJOLVI at room temperature between 68°F to 77°F (20°C to 25°C).
- Do not freeze DOJOLVI.
- When the bottle of DOJOLVI has been opened, use within 9 months or by the expiration date on the bottle, whichever comes first.
- Do not store DOJOLVI in containers made of polystyrene or polyvinyl chloride (PVC).
- Store DOJOLVI at room temperature between 68°F to 77°F.
- Instruct the patient or caregiver to store DOJOLVI at room temperature in the bottle in which it was dispensed [see How Supplied/Storage and Handling (16) ] .
FDA label version 17, effective June 10, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.